Steric hindrance of antibody binding in an Omicron spike fusion intermediate

Low, J. S. et al. ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. Science 377 , 735–741 (2022). ADS CAS PubMed PubMed Central Google Scholar Sun, X. et al. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2. Nat. Microbiol. 7 , 1063–1074 (2022). CAS PubMed Google Scholar Qu, P. K. et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 31 , 9–17.e3 (2023). CAS PubMed Google Scholar Wang, Q. et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell 186 , 279–286.e278 (2023). ADS CAS PubMed Google Scholar Chen, Y. J. et al. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nat. Rev. Immunol. 23 , 189–199 (2023). CAS PubMed Google Scholar Ling, Z. Y., Yi, C. Y., Sun, X. Y., Yang, Z. & Sun, B. Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies. Sci. China Life Sci. 66 , 658–678 (2023). CAS PubMed Google Scholar Dacon, C. et al. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science 377 , 728–735 (2022). ADS CAS PubMed PubMed Central Google Scholar Bianchini, F. et al. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein. Sci. Immunol. 8 , eade0958 (2023). CAS PubMed PubMed Central Google Scholar Marcink, T. C. …